Skip to main content

Humulin R U-500, Humulin R U-500 KwikPen

Unverified·never
Manufacturer
Eli Lilly
ICD-10 indication
E11.9

Affordability Check

How much will you actually pay for Humulin R U-500, Humulin R U-500 KwikPen?

In 30 seconds, see every legitimate way to afford Humulin R U-500, Humulin R U-500 KwikPen — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Humulin R U-500, Humulin R U-500 KwikPen

What is this medication? Humulin R U-500 and the Humulin R U-500 KwikPen are concentrated forms of regular human insulin used to manage blood sugar levels in patients with diabetes mellitus. This medication is specifically designed for individuals who have severe insulin resistance and require high daily doses, generally more than 200 units per day. Because it contains 500 units of insulin per milliliter, it is five times more potent than standard insulin, allowing patients to inject a smaller volume of liquid to receive the necessary high dose.

The medication serves a dual purpose by acting as both a mealtime insulin to cover glucose spikes and a basal insulin to maintain steady levels throughout the day and night. It is available in a vial for use with specific U-500 syringes or as a pre-filled KwikPen to ensure accurate dosing and ease of use. By concentrating the insulin, this treatment helps simplify the injection routine for those who would otherwise need multiple high-volume injections of less concentrated products.

Copay & patient assistance

  • Patient Copay Amount: $35 per 30-day supply for all covered Lilly insulins.
  • Maximum Annual Benefit Limit: Up to $16,000 per calendar year for patients with commercial insurance coverage; Program is also limited to 14–16 prescription fills per calendar year depending on the patient's insurance coverage status.
  • Core Eligibility Restrictions: Patients must be 18 years of age or older and a resident of the United States or its territories. Individuals enrolled in any state or federal government-funded healthcare program—including Medicare, Medicaid, TRICARE, VA, or DoD—are ineligible. The program is also unavailable to those enrolled in Alternate Funding Programs (AFPs).
  • RxBIN, PCN, and Group numbers: Not Publicly Available.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.